Posted 28th August 2019 by Jane Williams
Following the 5th Digital Pathology & AI Congress: USA, we have made the following presentation slides available from Iman Hajirasouliha, Kim Solez and Mrinal Mandal.
Posted 16th August 2019 by Jane Williams
Andrew Cook has worked in the pharmaceutical industry for over 20 years. Throughout his career, he has endeavoured to do things differently, a little out of the ordinary, leading him to his work at H3 Biomedicine on splice modulators. “Part of the reason it attracted me” he says, “is it’s so different. It’s a natural product-based drug discovery effort, and I had never done that before”.
Posted 2nd August 2019 by Jane Williams
With a background in pharmacology, toxicology, molecular cell biology and genetics, Rangaprasad Sarangarajan joined BERG Health in 2010 as head of R&D.
In the initial years of the company, he aided in the conception, design, and implementation of the paradigm of looking at human biology, use of technology to generate molecular signatures, and the use of artificial intelligence-based analytics for understanding the complexity of biology, identifying of targets, and developing of drugs, and its utility in clinical development.
Posted 17th May 2019 by Joshua Sewell
Radiology is ahead of the curve because they’ve had CAD (Computer Aided Detection) for about 20 years. Radiology as a field has therefore had experience of introducing and integrating AI algorithms.
In my previous post, I talked about high-level cross imaging modalities. Here, I will discuss three challenges specific to pathology. I also work with Radiology imaging, and I think that comparisons between the two can help see how pathology might develop in the future.
Posted 10th May 2019 by Joshua Sewell
Unsurprisingly, there is a lot of hype surrounding AI. Available deep learning packages make it so easy to create models and so we can expect lots of them to emerge. Anyone able to access sufficiently labelled data can start building models.
Posted 3rd May 2019 by Joshua Sewell
In our lab of Quantitative Imaging and Artificial Intelligence, we’re developing AI applications in a variety of areas, such as radiology and pathology. The goal is to develop applications that meet unmet medical needs, particularly in relation to precision medicine and clinical prediction.
Posted 17th April 2019 by Joshua Sewell
David Snead is Consultant Histopathologist and Clinical lead for Coventry and Warwickshire Pathology Services (CWPS), a network of labs hosted by University Hospitals of Coventry and Warwickshire NHS Trust. As head of the UHCW Digital Pathology Centre of Excellence, he is now heavily involved in the Pathology image data Lake for Analytics, Knowledge, and Education (PathLAKE).
Posted 5th April 2019 by Joshua Sewell
Aiforia Technologies is a medical AI software company seeking to transform clinical pathology and medical research by bringing deep learning AI to assist and augment human experts in medical image analysis.
We had the chance to ask CEO Kaisa Helminen about AI in healthcare and Aiforia’s newest platform.